Standigm uses Synthia Retrosynthesis Software from Merck KGaA, Darmstadt, Germany, to accelerate its drug design and synthesis processes driving advancements in pharmaceutical development. Standigm ...
Cell-based architectures offer a robust approach to building resilient systems. They achieve this through the core principles of isolation, autonomy, and replication. Each cell manages its resources ...